Inditel AH 40 Tablet is a combination antihypertensive medication containing Telmisartan 40 mg, Amlodipine 5 mg, and Hydrochlorothiazide 12.5 mg. This formulation is designed to effectively manage hypertension by targeting multiple physiological pathways. Telmisartan, an angiotensin II receptor blocker (ARB), inhibits the vasoconstrictive effects of angiotensin II, thereby reducing peripheral vascular resistance and lowering blood pressure. Amlodipine, a calcium channel blocker, promotes vasodilation by inhibiting calcium influx into vascular smooth muscle cells, further aiding in blood pressure reduction and improving myocardial oxygen delivery. Hydrochlorothiazide, a thiazide diuretic, facilitates the excretion of sodium and water, decreasing blood volume and contributing to antihypertensive effects. The combination of these agents provides a synergistic approach, improving blood pressure control in patients inadequately managed by monotherapy or dual therapy. Inditel AH 40 Tablet is indicated for the treatment of essential hypertension and may reduce the risk of cardiovascular events associated with elevated blood pressure. It should be used under medical supervision, with monitoring for potential side effects such as electrolyte imbalances, hypotension, and renal function alterations. Dose adjustments may be necessary in patients with renal or hepatic impairment.